Alterations of beta-adrenoceptor mediated relaxations of atherosclerotic human coronary arteries

Area of Science:

• Cardiovascular Biology
• Vascular Physiology
• Atherosclerosis Research

Background:

• Atherosclerosis is a cardiovascular disease characterized by plaque buildup in arteries.
• Previous studies suggested atherosclerosis may impair beta-adrenergic relaxations in coronary arteries.
• The specific mechanisms and scope of this impairment remained unclear.

Purpose of the Study:

• To investigate the impact of atherosclerosis on human coronary artery relaxation.
• To determine if impaired relaxation is specific to beta-adrenergic agonists or a general vascular dysfunction.
• To compare responses to isoproterenol with non-adrenergic vasodilators in atherosclerotic arteries.

Main Methods:

• Human coronary artery segments from 35 donors (aged 18-58) with varying atherosclerosis severity were studied.
• Vascular rings were precontracted with KCl (15 mM).
• Concentration-response curves for isoproterenol, forskolin, nitroglycerin, and SIN1 were generated and compared based on histological atherosclerosis scoring (Class II and III).

Main Results:

• Severe atherosclerosis (Class II and III) significantly reduced maximal relaxation to isoproterenol (from 76% to 33% and 22%, respectively).
• Maximal relaxations to forskolin, nitroglycerin, and SIN1 were not significantly altered by atherosclerosis.
• Atherosclerosis (Class III) caused a rightward shift in dose-response curves for nitroglycerin and SIN1, indicating altered sensitivity.

Conclusions:

• Atherosclerosis markedly attenuates beta-adrenergic relaxations in human coronary arteries.
• This specific impairment is not due to a general loss of vascular smooth muscle relaxation ability.
• The findings highlight a specific dysfunction in beta-adrenergic signaling pathways in atherosclerotic coronary vessels.